/
HAE
$75.12-$2.17 (-2.81%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$3.5B
45M shares
52-week range
$47.32 – $87.32
70% from low
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NYSE
CS
Price (6 mo)
Loading chart…
Change+$8.48
Haemonetics Corporation
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.
www.haemonetics.com- Employees
- 3,009
- IPO / List date
- May 9, 1991
- HQ
- BOSTON, MA
Held by traders on TradeandTell
No one on the platform currently holds HAE.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Bridgewater Associatesas of 2026-03-31 | 48,377 | $2.7M |
| Renaissance Technologiesas of 2026-03-31 | 43,200 | $2.4M |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2012-12-03 | 2-for-1 |
Recent trades on TradeandTell
No one on the platform has traded HAE yet.
